Patents by Inventor William Guy Love

William Guy Love has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inhibiting microbial biofilms
    Patent number: 9326511
    Abstract: The invention provides the use of a compound of formula (I), or metallated derivative thereof, for killing, inhibiting or preventing the growth of a microbial biofilm: wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 and Z have meanings given in the description. The biofilm may be on a living or inert support. Preferably, the microorganisms are selected from the group consisting of bacteria and fungi.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: May 3, 2016
    Assignee: Destiny Pharma Limited
    Inventors: William Guy Love, William Rhys-Williams
  • Novel Uses
    Publication number: 20110262511
    Abstract: The invention provides the use of a compound of formula (I), or metallated derivative thereof, for killing, inhibiting or preventing the growth of a microbial biofilm: wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 and Z have meanings given in the description. The biofilm may be on a living or inert support. Preferably, the microorganisms are selected from the group consisting of bacteria and fungi.
    Type: Application
    Filed: October 23, 2009
    Publication date: October 27, 2011
    Inventors: William Guy Love, William Rhys-Williams
  • Porphyrin derivatives their use in photodynamic therapy and medical devices containing them
    Patent number: 6630128
    Abstract: There is provided a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, Y1, Y2, Y3, Z, M, A-B and C-D have meanings given in the description, which are useful in the treatment of medical conditions for which a photodynamic compound is indicated. Compositions, apparatus and methods of treatment of a medical condition for which a photodynamic compound is indicated are also disclosed.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: October 7, 2003
    Assignees: Destiny Pharma Limited, University of East Anglia
    Inventors: William Guy Love, Michael John Cook, David Andrew Russell
  • Pharmaceutical compositions
    Patent number: 6465439
    Abstract: A pharmaceutical composition is disclosed comprising (A) and oligonucleotide having 5 to 50 nucleotide units, which is specifically hybridizable with DNA or RNA derived from a protein kinase C gene, entrapped in (B) sterically stabilized liposomes.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: October 15, 2002
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Paul Leslie Nicklin, Judith Ann Phillips, William Guy Love, Karen Ophelia Hamilton
  • Liposomal oligonucleotide compositions
    Patent number: 6096720
    Abstract: A pharmaceutical composition comprising (A) an oligonucleotide 8 to 50 nucleotides in length, which is targeted to mRNA encoding human raf and is capable of inhibiting raf expression, entrapped in (B) sterically stabilized liposomes.
    Type: Grant
    Filed: April 23, 1998
    Date of Patent: August 1, 2000
    Assignee: Novartis AG
    Inventors: William Guy Love, Paul Leslie Nicklin, Karen Ophelia Hamilton, Judith Ann Phillips
  • Topical pharmaceutical compositions
    Patent number: 5723148
    Abstract: A topically administrable pharmaceutical composition comprising (A) zinc phthalocyanine, (B) as carrier for (A), (i) a monoalkyl ether of diethyleneglycol substantially in the absence of a N-alkylpyrrolidone, a N,N-dialkylbenzamide or dimethyl sulphoxide, or (ii) a mixture of a monoalkyl ether of diethyleneglycol with a lipid and (C) a gelling agent.
    Type: Grant
    Filed: January 5, 1996
    Date of Patent: March 3, 1998
    Assignee: Novartis Corp.
    Inventor: William Guy Love